Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Investigation of the Efficacy of Mercury Chelation as a Treatment for Autism Spectrum Disorder

NCT00376194 is registered in ClinicalTrials.gov with National Institute of Mental Health (NIMH) as lead sponsor.

NCT NCT00376194
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00376194 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Investigation of the Efficacy of Mercury Chelation as a Treatment for Autism Spectrum Disorder
Lead sponsor
National Institute of Mental Health (NIMH)
Phase
Phase 2
Overall status
Withdrawn
Start date
September 30, 2006
Completion date
March 31, 2007
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asperger's disorder, autism, child development disorders, pervasive